| |
|
|
|
Xtalks, Online
2024-10-09
Discover an illuminating webinar on proteolysis targeting chimeras (PROTACs), a game-changing technology that is revolutionizing drug discovery and beyond. These catalytic entities are transforming biomedical research, drug discovery and agrochemical industries by selectively degrading specific proteins, including traditionally “undruggable” targets.
In this webinar, the expert speakers will cover key aspects shaping the future of PROTACs:
Decoding PROTACs: Explore the unique mechanism behind PROTACs and what makes them unique as targeted protein degraders
Biomedical Breakthroughs: Uncover how PROTACs are paving the way for new treatments for a spectrum of diseases, from cancer to neurodegenerative disorders
Precision Redefined: Learn how PROTACs offer targeted therapies with reduced side effects, promising a new era in personalized medicine
Crop Protection Reinvented: Discuss the potential of PROTACs in enhancing crop protection and sustainable agriculture practices
Register for this webinar today to understand the versatile and potent capabilities of PROTACs and their potential impact in biomedical research, drug discovery and agrochemicals.
Keywords: Drug Development, Drug Discovery, Personalized Medicine, Clinical Research, Biotech, CRO, Oncology, Proteomics, Therapeutic Areas, CNS, Protein Therapeutic, Targeted Protein Degradation, Basic Research
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Shanavas Alikunju, PhD, SVP & Head, Discovery Biology Solutions, Aragen Life Sciences
Indrani Sarkar, AVP, Assay Development and Screening, Discovery Biology Solutions, Aragen Life Sciences
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-10-09
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|